Brexpiprazole LAI, 1M & 2M
Agitation Associated with Alzheimer’s Dementia, Schizophrenia, Major Depressive Disorder
Pre-clinicalActive
Key Facts
Indication
Agitation Associated with Alzheimer’s Dementia, Schizophrenia, Major Depressive Disorder
Phase
Pre-clinical
Status
Active
Company
About Bostal Pharma
Bostal LLC is a private, technology-driven pharmaceutical company with a strategic focus on developing long-acting injectable (LAI) products using its proprietary drug delivery platforms. The company leverages a 505(b)(2) regulatory pathway to reformulate established molecules, aiming to improve dosing convenience and adherence in therapeutic areas like metabolic and neuropsychiatric disorders. With integrated R&D and GMP manufacturing capabilities, Bostal seeks global partnerships to co-develop and commercialize its pipeline candidates.
View full company profile